Report ID: 10078255 |
Published Date: 21 Oct 2022 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
Global Bone Growth Stimulator Industry was valued at USD 1.15 Billion in the year 2017. Global Bone Growth Stimulator Industry is further estimated to grow at a CAGR of 4.13% from 2018 to reach USD 1.58 Billion by the year 2025. North America region holds the highest Industry share in 2017 and Asia-Pacific Industry is considered as the fastest growing Industry in the forecasted period due to growing old age population. At a country level, the U.S in North America whereas India and China in Asia-Pacific is projected to grow strongly in the coming years.
Major market players in Bone Grwth Stimulator Industry are Medtronic plc, Stryker Corporation, Arthrex Inc., Regen Lab SA, Altis Biologics (Pty) Ltd, Johnson & Johnson (J&J), DePuy Synthes, DJO Global Inc., Terumo BCT Inc., Harvest Technologies (A Terumo BCT Company), Bioventus LLC, Orthofix International N.V., and other 10 more companies detailed information is provided in research report. Better global reach at an operational level is the main reason the key players are holding substantial Industry share. Rising research and development expenses to satisfy the changing demands of end users, new product launches and organic growth strategies were few techniques adopted by various manufacturers in last 5 years.
SWOT Analysis of Bone Growth Stimulator Industry:
Strength:
Growing old age population
Adoption of minimal surgical treatment
Weakness:
High treatment costs
Opportunities:
Rising pharma sector in emerging Industry
Threats:
Government Regulations and norms.
The segmentation are done on the basis of product type, by application, by end users and by region. On the basis of product types, the global Bone Growth Stimulator Industry is sub segmented as Bone Morphogenetic Proteins, Bone Growth Stimulation Devices and Platelet-Rich Plasma of which the Bone Growth Stimulation Devices segment is expected to hold the highest Industry share during the forecast period.
By Product
• Bone Morphogenetic Proteins
• Bone Growth Stimulation Devices
o External Bone Growth Stimulators
o Implanted Bone Growth Stimulators
o Ultrasonic Bone Growth Stimulators
• Platelet-Rich Plasma
By Application
• Delayed Union & Nonunion Bone Fractures
• Oral and Maxillofacial Surgeries
• Spinal Fusion Surgeries
• Other Applications
• End Users
• Hospitals & Clinics
• Home Care
• Others
By Region
North America
• USA
• Canada
Europe
• Germany
• U.K.
• France
• Italy
• Rest of Europe
APAC
• China
• India
• Japan
• Rest of Asia-Pacific
RoW
• Latin America
• Middle East & Africa
1
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
Report ID: 10078255 |
Published Date: 21 Oct 2022 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
